Buy Recommendation Issued On BBIO By H.C. Wainwright

October 28, 2025 10:15:19 am

Source: KlickAnalytics

2025-10-28 10:15:19 ET

H.C. Wainwright analyst issues BUY recommendation for BBIO on October 28, 2025 10:10AM ET.

The previous analyst recommendation was Buy.

BBIO was trading at $63.1788 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 22 - Buy, 1 - Hold recommendations .

Latest 10 recommendations
Full story available on KlickAnalytics.com

BridgeBio Pharma Inc.

-0.28% G/L:

$68.82 Last:

846,114 Volume:

$70.43 Open:

March 11, 2026 02:00:00 pm

March 10, 2026 05:15:05 pm

March 04, 2026 07:30:00 am

February 24, 2026 07:08:28 pm

Market Cap $13,905,867,946

Float 157,635,809

Insiders Ownership 2.34%

Institutions 155

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Palo Alto